Asvik Pharma And Chemicals Private Limited

Chemical manufacturing and intermediates for Acharya Group since 1996.

1996 | Mumbai, Maharashtra (India) | Active
Last Updated: October 23, 2024

Asvik Pharma And Chemicals Profile

Key Indicators

  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.50 Cr
  • Company Age 28 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 2.00 Cr
  • Revenue Growth -54.50%
  • Profit Growth 5.95%
  • Ebitda 5.09%
  • Net Worth -50.77%
  • Total Assets -15.68%

About Asvik Pharma And Chemicals

Asvik Pharma And Chemicals Private Limited (APACPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 November 1996 and has a history of 28 years and two months. Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Chemicals And Materials Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.50 Cr.

The company has closed loans amounting to ₹2.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

Shrikant Acharya, Usha Acharya, Anand Acharya, and Two other members serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24230MH1996PTC104252

  • Company No.

    104252

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    29 Nov 1996

  • Date of AGM

    25 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Chemicals and Materials

Who are the key members and board of directors at Asvik Pharma And Chemicals?

Board Members (5)

NameDesignationAppointment DateStatus
Shripati Acharya Country flag representing In Director 01-Sep-2000Current
Shrikant Acharya Country flag representing In Director 01-Sep-1999Current
Usha Acharya Country flag representing In Director 01-Sep-2000Current
Anand Acharya Country flag representing In Director 01-Sep-1999Current
Venkatraman Bhagwat Country flag representing In Director 25-Jul-2003Current

Financial Performance of Asvik Pharma And Chemicals.

Asvik Pharma And Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 54.5% decrease. The company also saw a slight improvement in profitability, with a 5.95% increase in profit. The company's net worth observed a substantial decline by a decrease of 50.77%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-54.50%
Revenue from Operations
-55.00%
Total Assets
-15.68%
Profit or Loss
5.95%
Net Worth
-50.77%
EBITDA
5.09%

What is the Ownership and Shareholding Structure of Asvik Pharma And Chemicals?

In 2023, Asvik Pharma And Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹2.00 Cr

Charges Breakdown by Lending Institutions

  • The Zoroastrian Co-Operative Bank Limited : 1.50 Cr
  • The Saraswat Co-Operative Bank Limited : 0.50 Cr

Latest Charge Details

DateLenderAmountStatus
30 Jun 2012The Zoroastrian Co-Operative Bank Limited₹6.00 MSatisfied
28 Jun 2012The Zoroastrian Co-Operative Bank Limited₹9.00 MSatisfied
05 Apr 2011The Saraswat Co-Operative Bank Limited₹5.00 MSatisfied

How Many Employees Work at Asvik Pharma And Chemicals?

Asvik Pharma And Chemicals has a workforce of 22 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Asvik Pharma And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asvik Pharma And Chemicals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Asvik Pharma And Chemicals

Recent activity within the organization

  • Annual General Meeting

    Asvik Pharma And Chemicals Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records.

    25 Sep 2024

  • Balance Sheet

    Asvik Pharma And Chemicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

    31 Mar 2024

  • Charges

    A charge registered on 28 Jun 2012 via Charge ID 10369327 with The Zoroastrian Co-Operative Bank Limited was fully satisfied on 25 Jul 2018.

    25 Jul 2018

  • Charges

    A charge registered on 30 Jun 2012 via Charge ID 10369328 with The Zoroastrian Co-Operative Bank Limited was fully satisfied on 27 Sep 2013.

    27 Sep 2013

  • Charges

    A charge registered on 05 Apr 2011 via Charge ID 10284951 with The Saraswat Co-Operative Bank Limited was fully satisfied on 29 Aug 2012.

    29 Aug 2012

  • Charges

    A charge with The Zoroastrian Co-Operative Bank Limited amounted to Rs. 0.60 Cr with Charge ID 10369328 was registered on 30 Jun 2012.

    30 Jun 2012

Frequently asked questions

  • Asvik Pharma And Chemicals Private Limited was incorporated on 29 Nov 1996.

  • The authorized share capital of Asvik Pharma And Chemicals Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 1.50 Cr.

  • Currently 5 directors are associated with Asvik Pharma And Chemicals Private Limited.

    • Shrikant Narahari Acharya
    • Usha Shrinivas Acharya
    • Anand Shriniwas Acharya
    • Venkatraman Narayan Bhagwat
    • Shripati Narahari Acharya
  • As per Ministry of Corporate Affairs (Mca), the registered address of Asvik Pharma And Chemicals Private Limited is Sai Jyot Office No.105 1St Floor Neepa Chs Junction Of S. N. Road L . Road, India, Mulund West, Maharashtra, 400080.

  • The corporate identification number (CIN) of Asvik Pharma And Chemicals Private Limited is U24230MH1996PTC104252 and the company number is 104252 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Asvik Pharma And Chemicals Private Limited is https://www.acharyagroup.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Asvik Pharma And Chemicals Private Limited has fallen by -54.50%.

  • As Per 2023 financial reports, 22 employees are currently employed by Asvik Pharma And Chemicals Private Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Asvik Pharma And Chemicals Private Limited has experienced an downturn of -50.77%.

  • The most recent Balance Sheet for Asvik Pharma And Chemicals Private Limited was filed with the ROC on 31 Mar 2024.